Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 11—November 2012

Extensively Drug-Resistant Tuberculosis, Central China, 2007–2009

Dawei Shi, Hui Li, Yuling Zhao, Qiong Jia, Christopher Coulter, Liang Li1, and Guofeng Zhu1Comments to Author 
Author affiliations: Institute of Pathogen Biology of Chinese Academy of Medical Sciences, Beijing, China (D. Shi, Q. Jia, G. Zhu); Peking Union Medical College, Beijing (D. Shi, Q. Jia, G. Zhu); National Institute for the Control of Pharmaceutical and Biological Products, Beijing (D. Shi); Henan Provincial Centers for Disease Control and Prevention, Zhengzhou, China (H. Li, Y. Zhao); Pathology Queensland, Brisbane, Queensland, Australia (C. Coulter); and Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing (L. Li)

Main Article


Second-line drug resistance patterns for 143 strains of multidrug-resistant tuberculosis, Henan Province, China, 2007–2009*

Drugs No. (%) strains
INH + RIF 84 (58.7)
INH + RIF + KAN 1 (0.7)
INH + RIF+ CAP 3 (2.1)
INH + RIF + KAN + AMI 1 (0.7)
INH + RIF+ KAN + CAP 1 (0.7)
INH + RIF+ KAN + AMI + CAP 4 (2.8)
INH + RIF+ OFX 31 (21.7)
INH + RIF + OFX + KAN 1 (0.7)
INH + RIF+ OFX + CAP 2 (1.4)
INH + RIF+ OFX + KAN + CAP 3 (2.1)
INH + RIF+ OFX + KAN + AMI + CAP 12 (8.4)
Total 143 (100%)

*INH, isoniazid; RIF, rifampin; KAN, kanamycin; CAP, capreomycin; AMI, amikacin; OFX, ofloxacin.

Main Article

1These authors contributed equally to this article.

Page created: October 15, 2012
Page updated: October 15, 2012
Page reviewed: October 15, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.